104 related articles for article (PubMed ID: 24881310)
1. [Economic efficiency of renal denervation in patients with resistant hypertension: results of Markov modeling].
Kontsevaia AV; Suvorova EI; Khudiakov MB
Kardiologiia; 2014; 54(1):41-7. PubMed ID: 24881310
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of renal denervation therapy for the treatment of resistant hypertension in The Netherlands.
Henry TL; De Brouwer BF; Van Keep MM; Blankestijn PJ; Bots ML; Koffijberg H
J Med Econ; 2015 Jan; 18(1):76-87. PubMed ID: 25367314
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.
Geisler BP; Egan BM; Cohen JT; Garner AM; Akehurst RL; Esler MD; Pietzsch JB
J Am Coll Cardiol; 2012 Oct; 60(14):1271-7. PubMed ID: 22981547
[TBL] [Abstract][Full Text] [Related]
4. Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.
Dorenkamp M; Bonaventura K; Leber AW; Boldt J; Sohns C; Boldt LH; Haverkamp W; Frei U; Roser M
Eur Heart J; 2013 Feb; 34(6):451-61. PubMed ID: 23091202
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of renal denervation therapy for the treatment of resistant hypertension in the UK.
Gladwell D; Henry T; Cook M; Akehurst R
Appl Health Econ Health Policy; 2014 Dec; 12(6):611-22. PubMed ID: 25086585
[TBL] [Abstract][Full Text] [Related]
6. [Renal denervation for the treatment of resistant hypertension: definition, patient selection and description of the procedure. 2012 Position paper of the Italian Society of Hypertension].
Volpe M; Agabiti-Rosei E; Ambrosioni E; Cottone S; Cuspidi C; Borghi C; De Luca N; Fallo F; Ferri C; Mancia G; Morganti A; Muiesan ML; Sarzani R; Sechi L; Tocci G; Virdis A;
G Ital Cardiol (Rome); 2012 Dec; 13(12):846-52. PubMed ID: 23196688
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of resistant hypertension with percutaneous renal denervation therapy.
Ong PJ; Foo D; Ho HH
Heart; 2012 Dec; 98(23):1754-5. PubMed ID: 22821275
[No Abstract] [Full Text] [Related]
8. [Renal denervation in resistant hypertension: proposal for a common multidisciplinary attitude].
Muller O; Qanadli SD; Waeber B; Wuerzner G
Rev Med Suisse; 2012 May; 8(343):1159-60, 1162-3. PubMed ID: 22741177
[TBL] [Abstract][Full Text] [Related]
9. Renal denervation in the management of resistant hypertension: current evidence and perspectives.
Jin Y; Persu A; Staessen JA
Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):511-8. PubMed ID: 23892701
[TBL] [Abstract][Full Text] [Related]
10. [Renal denervation in the treatment of hypertension].
Tikkanen I; Lappalainen K
Duodecim; 2013; 129(8):825-32. PubMed ID: 23720950
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life after renal denervation in patients with treatment-resistant hypertension.
Lambert GW; Hering D; Esler MD; Marusic P; Lambert EA; Tanamas SK; Shaw J; Krum H; Dixon JB; Barton DA; Schlaich MP
Hypertension; 2012 Dec; 60(6):1479-84. PubMed ID: 23071129
[TBL] [Abstract][Full Text] [Related]
12. Catheter-based renal denervation in the treatment of resistant hypertension.
Stouffer GA; Dibona GF; Patel A; Kaul P; Hinderliter AL
J Mol Cell Cardiol; 2013 Sep; 62():18-23. PubMed ID: 23660548
[TBL] [Abstract][Full Text] [Related]
13. "In-stent" renal denervation for the treatment of severe resistant hypertension.
Marchese A; Secco GG; Chierchia S; Iorio E; Castriota F
Int J Cardiol; 2014 May; 173(3):e25-6. PubMed ID: 24713456
[No Abstract] [Full Text] [Related]
14. 3D-sympathetic renal denervation increases procedural efficacy in non-responders after percutaneous renal denervation: dream or reality with second generation of devices.
Versaci F; Nardi S; Trivisonno A; Olivieri C; Caranci F; Prati F
Int J Cardiol; 2014 Aug; 175(2):370-1. PubMed ID: 24820742
[No Abstract] [Full Text] [Related]
15. Three-dimensional guided renal denervation to treat drug-resistant arterial hypertension in a patient with renal insufficiency.
Lewalter T; Brodherr T
Hypertension; 2012 Oct; 60(4):e33. PubMed ID: 22914794
[No Abstract] [Full Text] [Related]
16. [Renal denervation a treatment for resistant hypertension: a French experience].
Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
[TBL] [Abstract][Full Text] [Related]
17. Renal denervation for resistant hypertension.
Almeida Mde S; Gonçalves Pde A; Oliveira EI; Carvalho HC
Rev Port Cardiol; 2015 Feb; 34(2):125-35. PubMed ID: 25662472
[TBL] [Abstract][Full Text] [Related]
18. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
[TBL] [Abstract][Full Text] [Related]
19. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension.
Ukena C; Mahfoud F; Kindermann I; Barth C; Lenski M; Kindermann M; Brandt MC; Hoppe UC; Krum H; Esler M; Sobotka PA; Böhm M
J Am Coll Cardiol; 2011 Sep; 58(11):1176-82. PubMed ID: 21884958
[TBL] [Abstract][Full Text] [Related]
20. Advances in catheter-based renal denervation can help the uncontrolled hypertensive patient.
Morrow T
Manag Care; 2012 Dec; 21(12):45-6. PubMed ID: 23301350
[No Abstract] [Full Text] [Related]
[Next] [New Search]
